Back to Products
-18%Hot
CJC-1295 + IPAMORELIN 5/5MG - Image 1

CJC-1295 + IPAMORELIN 5/5MG

This blend combines a Growth Hormone Releasing Hormone (GHRH) analog, CJC-1295, with a Growth Hormone Secretagogue (GHS), Ipamorelin. This combination is researched for its synergistic effect on stimulating the pituitary gland to release growth hormone.

Learn more

Original price was: $110.00.Current price is: $90.00.

Add to wishlist

The information provided on this page is intended solely as a general summary. It does not encompass all potential research applications, handling procedures, safety precautions, interactions, or observed effects. These products are supplied strictly for laboratory and research purposes only. They are not intended for human consumption, medical use, veterinary use, or diagnostic purposes. This information must not be considered a substitute for professional expertise, judgment, or regulatory guidance.

Money Back Guarantee

Guaranteed Quality

Fast Shipping

10+ Years Experience

Frequently Bought Together

-26%-18%Hot
Add to wishlist

CJC-1295 + IPAMORELIN 5/5MG

, , , ,
Original price was: $110.00.Current price is: $81.00.
Quick view
-29%-21%
Add to wishlist

FOLLISTATIN 344 1MG

,
Original price was: $140.00.Current price is: $99.00.
Quick view
-10%
Add to wishlist

PEG-MGF 2MG

, ,
Original price was: $50.00.Current price is: $45.00.
Quick view
-29%-22%Hot
Add to wishlist

BPC-157 + TB500

, , ,
Price range: $90.00 through $130.50
Quick view
Original price was: $110.00.Current price is: $81.00.
Original price was: $140.00.Current price is: $99.00.
Original price was: $50.00.Current price is: $45.00.
Original price was: $110.00.Current price is: $90.00.
Original price was: $410.00.Current price is: $315.00.
For 4 items

SEQUENCE/FORMULA

CJC-1295 Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2 Molecular Formula: C152​H252​N44​O42 Ipamorelin Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2 Molecular Formula:

MOLECULAR WEIGHT

CJC-1295 3367.9 g/mol Ipamorelin 711.9 g/mol

PUBCHEM CID

CJC-1295 91971820 Ipamorelin 9831659
  • Researching its ability to naturally boost growth hormone levels
  • Investigating its effects on building lean muscle and improving body shape
  • Analyzing its potential to enhance sleep quality and speed up recovery
  • Studying its role in strengthening bones
  • Exploring its potential for cellular repair and anti-aging benefits
The blended formulation of CJC-1295 and Ipamorelin is designed to stimulate the pituitary gland to release growth hormone through two distinct and complementary pathways.
  • CJC-1295: As a GHRH analog, CJC-1295 binds to and stimulates the GHRH receptors on the anterior pituitary gland. This action mimics the effects of the endogenous GHRH, prompting the synthesis and release of a larger pulse of growth hormone. CJC-1295 is modified to have a longer half-life than natural GHRH, providing a more sustained stimulation.
  • Ipamorelin: As a selective growth hormone secretagogue (GHRP), Ipamorelin mimics the action of ghrelin. It binds to the ghrelin/growth hormone secretagogue receptor (GHSR) in the pituitary gland. This binding also stimulates the release of growth hormone. A key feature of Ipamorelin is its specificity for growth hormone release without significantly affecting the levels of other hormones such as cortisol or prolactin.
By combining these two peptides, researchers aim to achieve a more robust and synergistic release of growth hormone. CJC-1295 provides a foundational increase in the amount of growth hormone that can be released, while Ipamorelin acts as a potent trigger for the release itself, leading to a stronger and more sustained elevation of circulating growth hormone levels.
  • Teichman, S. L., et al. (2006). Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. Journal of Clinical Endocrinology & Metabolism, 91(3), 799-805.
  • Raun, K., et al. (1998). Ipamorelin, the first selective growth hormone secretagogue. European journal of endocrinology, 139(5), 552-561.
  • Sackmann-Sala, L., et al. (2012). Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in a clinically significant increase in body weight in mice. Journal of endocrinology.